Enveda Biosciences

About

Enveda Biosciences is a biotechnology company engineering new drugs from nature.

Boulder,Colorado,United States
101 - 250
https://envedabio.com/

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $55M
Industries: Biotechnology,Pharmaceutical,Therapeutics
Founded date: Jan 1, 2019
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Enveda Biosciences, Inc.

Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules.

Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.

Enveda, launched in 2019, is headquartered in Boulder, Colorado.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$123.90M

Enveda Biosciences has raised a total of $123.90M in funding over 2 rounds. Their latest funding was raised on Dec 21, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 21, 2022	Series B	$55M	12	Dimension Capital	—	Detail
Dec 21, 2022	Debt Financing	$13M	1	Silicon Valley Bank	—	Detail
Jun 22, 2021	Series A	$51M	10	Lux Capital	—	Detail
Jun 15, 2021	Series A	—	1	—	—	Detail
Aug 11, 2020	Seed	$4.90M	4	True Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

5

19

Enveda Biosciences is funded by 19 investors. Dimension Capital and Silicon Valley Bank are the most recent investors.

Investor Name	Lead Investor	Funding Round
Dimension Capital	Yes	Series B
Silicon Valley Bank	Yes	Debt Financing
Allen & Company	—	Series B
Amino Collective	—	Series B
FPV Ventures	—	Series B
Hummingbird Ventures	—	Series B
Jazz Venture Partners	—	Series B
Level Ventures	—	Series B
Lux Capital	—	Series B
Possible Ventures	—	Series B